83 related articles for article (PubMed ID: 9950251)
1. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis.
Tsai CC; Ma RH; Shieh TY
J Oral Pathol Med; 1999 Feb; 28(2):59-63. PubMed ID: 9950251
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast activating protein promotes the proliferation, migration, and activation of fibroblasts in oral submucous fibrosis.
Li M; Deng Z; Xie C; Chen J; Yuan Z; Rahhal O; Tang Z
Oral Dis; 2024 Apr; 30(3):1252-1263. PubMed ID: 37357365
[TBL] [Abstract][Full Text] [Related]
3. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).
Zhou L; Tan J; Dai Y; Zhu K; Xiao Y; Wu D; Wang Z; Tan Y; Qin Y
Drug Des Devel Ther; 2023; 17():3085-3101. PubMed ID: 37854130
[TBL] [Abstract][Full Text] [Related]
4. Polyphenol-based targeted therapy for oral submucous fibrosis.
Mehta CH; Paliwal S; Muttigi MS; Seetharam RN; Prasad ASB; Nayak Y; Acharya S; Nayak UY
Inflammopharmacology; 2023 Oct; 31(5):2349-2368. PubMed ID: 37106237
[TBL] [Abstract][Full Text] [Related]
5. DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis.
Wang SY; Zhang SJ; Meng HF; Xu HQ; Guo ZX; Yan JF; Gao JL; Niu LN; Wang SL; Jiao K
Stem Cell Res Ther; 2024 Apr; 15(1):113. PubMed ID: 38650025
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits arecoline-induced fibrotic properties of buccal mucosal fibroblasts via miR-200a activation.
Yang HW; Chun-Yu Ho D; Liao HY; Liao YW; Fang CY; Ng MY; Yu CC; Lin FC
J Dent Sci; 2024 Apr; 19(2):1028-1035. PubMed ID: 38618058
[TBL] [Abstract][Full Text] [Related]
7. Development of Epigallocatechin 3-gallate-Loaded Hydrogel Nanocomposites for Oral Submucous Fibrosis.
Mehta CH; Velagacherla V; Manandhar S; Nayak Y; Pai SRK; Acharya S; Nayak UY
AAPS PharmSciTech; 2024 Mar; 25(4):66. PubMed ID: 38519779
[TBL] [Abstract][Full Text] [Related]
8. Guideline for the Diagnosis and Clinical Management of Oral Submucous Fibrosis.
;
Chin J Dent Res; 2023 Dec; 26(4):271-285. PubMed ID: 38126373
[TBL] [Abstract][Full Text] [Related]
9. Oral submucous fibrosis in children: an alarming condition and challenges in management.
Rai A; Jain A; Arora A; Motiwale T
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33758041
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of two arecoline-induced oral submucous fibrosis models.
Tang S; Jiang L; Zhou Y; Zhou T; Peng Y; Zhou S; Yue Y; Xia X; Li J; Chen Q; Jiang Y; Feng X
Oral Dis; 2023 Dec; ():. PubMed ID: 38098250
[TBL] [Abstract][Full Text] [Related]
11. Oral Submucous Fibrosis Secondary to Iron Deficiency Anemia: A Case Report, Etiopathogenesis and Management.
Bhattacharya PT; Khaitan T; Sarkar SB; Sinha R
J Nutr Health Aging; 2016 Feb; 20(2):205-8. PubMed ID: 26812518
[TBL] [Abstract][Full Text] [Related]
12. Oxidative-protective effect of nuclear receptor coactivator 7 on arecoline-induced endothelial-to-mesenchymal transition.
Wang Y; Luo D; Yuan X; Luo Y; Cheng X; Gao Y; Xie X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):565-573. PubMed ID: 32988808
[TBL] [Abstract][Full Text] [Related]
13. Oral opening training increases oral opening in patients with oral submucous fibrosis.
Chen J; Wu Y; Peng J; Ma L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):731-735. PubMed ID: 34382590
[TBL] [Abstract][Full Text] [Related]
14. A Critical Interpretive Synthesis of the Role of Arecoline in Oral Carcinogenesis: Is the Local Cholinergic Axis a Missing Link in Disease Pathophysiology?
Gocol H; Zeng JH; Chang S; Koh BY; Nguyen H; Cirillo N
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139811
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of plasma fibrinogen degradation products, D-dimer, and mast cells in oral submucous fibrosis.
Sharma I; Wanjari S; Parwani R; Tekade S; Azad A; Azad A
J Oral Maxillofac Pathol; 2023; 27(3):438-442. PubMed ID: 38033933
[TBL] [Abstract][Full Text] [Related]
16. Oral Submucous Fibrosis Secondary to Buccal Mucosal Graft for Urethroplasty.
Ansari HM; Rao S; Sharma A; Galhotra V
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):5601-5603. PubMed ID: 36742534
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Oral Fibrinogenesis Through Transforming Growth Factor-Beta/SMAD2/3 Signalling Inhibition Using Mangosteen Pericarp Extract.
P JE; Tn U; Perumal E
Cureus; 2023 Oct; 15(10):e47899. PubMed ID: 38034260
[TBL] [Abstract][Full Text] [Related]
18. Systemic effect of arecoline on the gastrointestinal system in oral submucous fibrosis affected wistar rats.
Rajarathnam BN; Rakesh N; Murali A; Asha ML
J Oral Maxillofac Pathol; 2022; 26(4):598. PubMed ID: 37082066
[TBL] [Abstract][Full Text] [Related]
19. Factors Affecting the Evaluation of Collagen Deposition and Fibrosis
Fathi P; Sundaresan V; Alfonso AL; Rama Varma A; Sadtler K
Tissue Eng Part A; 2024 Apr; ():. PubMed ID: 38511512
[TBL] [Abstract][Full Text] [Related]
20. High-throughput assays show the timescale for phagocytic success depends on the target toughness.
Bakhtiari LA; Wells MJ; Gordon VD
Biophys Rev (Melville); 2021 Sep; 2(3):031402. PubMed ID: 34632456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
